Individuals suffering from treatment-resistant depression can access a new clinical option launched in Burlingame by Soft Reboot Wellness (+1 650-419-3330), which uses ketamine infusions to reduce symptoms
MD Infusions Offers Ketamine as a Novel Therapy for Anxiety, PTSD and OCD in Northbrook, Illinois
Share Article
MD Infusions Offers Ketamine as a Novel Therapy for Anxiety, PTSD and OCD in the Chicago Area
Our staff are uniquely qualified to sustain and improve patients quality of life, specializing in novel treatments such as ketamine therapy, NAD+ infusions, and IV vitamin infusions. CHICAGO (PRWEB) May 26, 2021 If you suffer from Anxiety, Post Traumatic Stress Disorder (PTSD), or Obsessive-Compulsive Disorder (OCD), there is an exciting new treatment option available. Ketamine therapy can reduce symptoms of these disorders and can provide relief for those who have not responded well to traditional medications. Ketamine therapy is an alternative treatment that offers new hope for people suffering from anxiety, PTSD, and OCD.
Shahriar SheikhBahaei, Ph.D.
Dr. SheikhBahaei’s interest in neuroscience stemmed from the usual combination of an aptitude for science and a medical problem (stuttering) that brought him into bioscience at a young age. Dr. SheikhBahaei received his bachelor’s degree from the University of California at Berkeley, where he worked with Dr. Bob Zucker on the regulation of neurotransmitter release and Dr. John Rubenstein (UC San Francisco) on development of GABAergic neurons in basal ganglia. Dr. SheikhBahaei completed his doctoral studies in Neuroscience (2017) jointly under NIMH/NINDS – University College London (UCL) Graduate Partnership Program where he worked with Drs. Jeffrey Smith (NINDS) and Alexander Gourine (UCL). His graduate studies were on how astrocytic networks control activities of respiratory motor circuits within the brainstem. After short postdoctoral research at NINDS, Dr. SheikhBahaei became an Independent Research Scholar in 2019. In collaboration with the lab